GB Sciences, Inc. (GBLX)
OTCMKTS
· Delayed Price · Currency is USD
0.0003
0.00 (0.00%)
Apr 29, 2026, 4:00 PM EST
GB Sciences Employees
GB Sciences had 2 employees as of March 31, 2024. The number of employees decreased by 1 or -33.33% compared to the previous year.
Employees
2
Change (1Y)
-1
Growth (1Y)
-33.33%
Revenue / Employee
$48,618
Profits / Employee
-$527,753
Market Cap
158.82K
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Innovation Pharmaceuticals | 4 |
| Lipella Pharmaceuticals | 7 |
| Scorpius Holdings | 91 |
| Regen BioPharma | 1 |
| Sigyn Therapeutics | 4 |
| Synairgen | 34 |
| Ocean Biomedical | 7 |
GB Sciences News
- 3 years ago - Gb Sciences Identifies Novel Cannabis-Inspired Mixtures as Anti-Inflammatory Therapies Based on Proprietary AI-Enabled Drug Discovery Platform - GlobeNewsWire
- 3 years ago - Gb Sciences Addresses Growing Need for Anxiety and Depression Medications With Non-Psychedelic, Kava-Based Formulations - GlobeNewsWire
- 3 years ago - Gb Sciences Co-Publishes Study Demonstrating Anti-Inflammatory Properties of Cannabis Ingredients - GlobeNewsWire
- 3 years ago - TODAY: Gb Sciences' President Demonstrates Benefits of AI-Enabled Drug Discovery Engine for Novel Plant-Inspired Pharmaceuticals at 10th Annual Drug Discovery Strategic Summit - GlobeNewsWire
- 3 years ago - Gb Sciences' Plant-based Formulations Designed to Treat Anxiety Achieve Statistical Significance in Animal Study - GlobeNewsWire
- 3 years ago - TODAY: Gb Sciences' President Demonstrates Effectiveness of Simplified Therapeutic Mixtures Inspired by Cannabis Plant Extracts at Canna Pharma 2022 Conference - GlobeNewsWire
- 3 years ago - Gb Sciences Co-Publishes Study Demonstrating Efficacy of Its Proprietary Cannabinoid Mixtures for the Treatment of Parkinson's Disease - GlobeNewsWire
- 3 years ago - TODAY: Gb Sciences Describes Drug Development Progress in Pharma's Almanac Journal Article - GlobeNewsWire